Job vacancy in Emcure pharmaceuticals walk-in on 11th may 2024

Job vacancy in Emcure pharmaceuticals walk-in on 11th may 2024 for M pharmacy, B pharmacy, Msc, Bsc, ITI, Diploma for multiple positions

 

Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune. Emcure’s product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables. The company is a major producer of HIV antivirals, as well as gynaecology and blood therapeutic drugs.

This is the list of manufacturing facilities based in India – Solid Dosage facility at Hinjwadi – In 2006, Emcure received US FDA approval for its solid dosages facility at Hinjwadi, Pune. The plant manufactures solid oral formulations for the international regulated markets, but is under FDA warning letter. Small volume parenteral facility at Hinjawadi – US FDA, UK MHRA approved. Has lyophilization and pfs capability, but is under FDA warning letter. Oncology injectable facility at Hinjawadi, but is under FDA warning letter. Solid Orals facilities at Jammu and Bhosari. API facility at Kurkumbh- US FDA approved. Biotech facility at Hinjawadi. R&D Center at Gandhinagar and plant at Sanand, Ahmedabad.- Sanand facility is US FDA approved.Heritage Pharmaceuticals, a former division of Emcure, entered into a deferred prosecution agreement with the United States Department of Justice, Antitrust Division (“DOJ”) relating to a one-count Information for a conspiracy involving glyburide. In conjunction with the DPA, Heritage agreed to pay a $225,000 fine. The DPA expired on May 30, 2022, and the United States District Court for the Eastern District of Pennsylvania dismissed with prejudice the one-count Information filed by the DOJ against Heritage on June 30, 2022. In addition, Heritage separately agreed to a settlement with the United States Department of Justice, Civil Division to resolve potential civil liability under the False Claims Act in connection with the antitrust conduct. Under the terms of the settlement, Heritage agreed to pay $7.1 million to the DOJ’s Civil Division.

More about company

https://emcure.com/

Job vacancy

Vacancy details –

Department – production ( Injectable plant)/ operator

Qualification – M pharmacy, B pharmacy, Msc, Bsc, ITI, Diploma

Experience – 01 to 08 year’s

 

Similar job’s

Job vacancy in Glenmark pharmaceuticals Ltd. Walk-in on 19th may 2024

There are allegations that Emcure (through its sister company Gennova) stole the technology of vaccine production by breaching contract with HDT Bio. Earlier Emcure broke ties with Roche in similar way. The USFDA had given Warning Letter for data integrity manipulation problems at Emcure plants. In 2010, Pfizer had to recall three batches of an anti-bacterial product from the US market due to presence of Bacillus anthracis, Penicillium chrysogenum & E. coli in some samples. Teva recalled several batches of two products due to white tablets showing presence of Yersinia pestis in 2011. Even in the domestic market, Maharashtra FDA issued a circular to recall all the injections (500 mg /10 ml) manufactured by Emcure Pharmaceuticals Ltd, from across the country. Two injected drugs manufactured by Emcure, with a history of sterility problems were recalled because of microbial contamination. The drugs were both manufactured by Emcure Pharmaceuticals but were distributed in the U.S. by Heritage Pharmaceuticals (now renamed Avet).

The plant manufactures solid oral formulations for the international regulated markets, but is under FDA warning letter. Small volume parenteral facility at Hinjawadi – US FDA, UK MHRA approved. Has lyophilization and pfs capability, but is under FDA warning letter. Oncology injectable facility at Hinjawadi, but is under FDA warning letter. Solid Orals facilities at Jammu and Bhosari. API facility at Kurkumbh- US FDA approved. Biotech facility at Hinjawadi. R&D Center at Gandhinagar and plant at Sanand, Ahmedabad.- Sanand facility is US FDA approved.Heritage Pharmaceuticals, a former division of Emcure, entered into a deferred prosecution agreement with the United States Department of Justice, Antitrust Division (“DOJ”) relating to a one-count Information for a conspiracy involving glyburide.

Important details –

Location – Gujarat

Selection process – The selection will be on the basis of interview

Mode of interview – Face to face

Interview rounds of interview- HR

Production ( Injectable plant)

Designation – Executive/ Officer

Experience – 02 to 07 years ( M pharmacy, B pharmacy, Msc, Bsc)

Operator

Experience – 01 to 08 year’s ( ITI, Diploma)

 

Walk-in interview details –

Date – 11th may 2024 ( Saturday)

Time – 10:00 Am to 02:00 Pm

Venue – Emcure pharmaceuticals Ltd. Plot no. SM-14-15-16/1 , GIDC II, Sanand, Ahmedabad , Gujarat.

Note –

Please bring photocopies of all your relevant documents like CTC proof, Education etc.

 

For more job related updates joined WhatsApp group

https://chat.whatsapp.com/KCk1lRtEdlJEJYDBTQNc9i

 

 

Leave a comment